StonvexLoading…
StonvexStonvexStonvexCore line items from CRBG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.96B | $18.48B | $11.71B | $6.33B |
Operating Income | $97.00M | $-541.00M | $-1.51B | $-1.47B |
Net Income | $-53.00M | $-366.00M | $-1.18B | $-1.32B |
EPS (Diluted) | $-0.11 | $-0.68 | $-2.15 | $-2.39 |
Total Assets | $407.06B | $413.55B | $411.29B | $399.16B |
Total Liabilities | $395.52B | $399.59B | $396.97B | $385.99B |
Cash & Equivalents | $378.00M | $453.00M | $322.00M | $296.00M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 456.73M | 496.37M | 532.11M | 543.19M |